Sustained injection of neuroblastoma and neuron-derived exosomes into the brains of APP transgenic mice have demonstrated the ability to capture Aβ, significantly lower Aβ levels and thus reducing the pathological burden of AD [85,122]. The gene discussed is APP; the disease is Alzheimer disease.